Literature DB >> 30209638

Transcatheter Mitral Valve Therapy: Defining the Patient Who Will Benefit.

Marvin H Eng1, Dee Dee Wang2.   

Abstract

PURPOSE OF REVIEW: This report aims to define the clinical and anatomic variables key in determining patient suitability for transcatheter mitral valve therapies. RECENT
FINDINGS: Candidacy for transcatheter mitral valve repair requires weighing the clinical variables that may impact the ability to improve patient symptoms and prolong survival that include left ventricular ejection fraction, symptom severity, pulmonary hypertension, and magnitude of residual regurgitation or stenosis. Individualized selection of transcatheter repair or replacement based on patho-anatomy is being explored. The primary goal is achieving significant reduction in mitral regurgitation. Transcatheter mitral valve replacement requires rigorous anatomic screening using computed tomography and candidates should be able to take oral anticoagulation. Selection of patients for transcatheter mitral valve repair is complex and requires intimate knowledge of clinical variables and specific device limitations.

Entities:  

Keywords:  Mitral valve; Percutaneous; Transcatheter; Valve repair; Valve replacement

Mesh:

Year:  2018        PMID: 30209638     DOI: 10.1007/s11886-018-1058-8

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  66 in total

1.  Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry.

Authors:  Henrique B Ribeiro; Luis Nombela-Franco; Antonio J Muñoz-García; Pedro Alves Lemos; Ignacio Amat-Santos; Vicenç Serra; Fabio S de Brito; Alexandre Abizaid; Rogério Sarmento-Leite; Rishi Puri; Asim N Cheema; Marc Ruel; Fabian Nietlispach; Francesco Maisano; Cesar Moris; Raquel Del Valle; Marina Urena; Omar Abdul Jawad Altisent; Maria Del Trigo; Francisco Campelo-Parada; Pilar Jimenez Quevedo; Juan H Alonso-Briales; Hipólito Gutiérrez; Bruno García Del Blanco; Marco Antonio Perin; Dimytri Siqueira; Guilherme Bernardi; Éric Dumont; Melanie Côté; Philippe Pibarot; Josep Rodés-Cabau
Journal:  J Am Coll Cardiol       Date:  2015-11-10       Impact factor: 24.094

2.  Predicting early left ventricular dysfunction after mitral valve reconstruction: the effect of atrial fibrillation and pulmonary hypertension.

Authors:  Robin Varghese; Shinobu Itagaki; Anelechi C Anyanwu; Federico Milla; David H Adams
Journal:  J Thorac Cardiovasc Surg       Date:  2013-10-28       Impact factor: 5.209

3.  Impact of percutaneous mitral valve repair using the MitraClip system on tricuspid regurgitation.

Authors:  Antonio H Frangieh; Christiane Gruner; Fran Mikulicic; Adrian Attinger-Toller; Felix C Tanner; Maurizio Taramasso; Roberto Corti; Jürg Grünenfelder; Thomas F Lüsche; Frank Ruschitzka; Dominique Bettex; Francesco Maisano; Oliver Gaemperli
Journal:  EuroIntervention       Date:  2016-04-08       Impact factor: 6.534

4.  Bleeding Complications After Percutaneous Mitral Valve Repair With the MitraClip.

Authors:  Maria Isabel Körber; Julia Silwedel; Kai Friedrichs; Victor Mauri; Michael Huntgeburth; Roman Pfister; Stephan Baldus; Volker Rudolph
Journal:  Am J Cardiol       Date:  2017-10-12       Impact factor: 2.778

5.  Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry.

Authors:  Eike Tigges; Stefan Blankenberg; R Stephan von Bardeleben; Christine Zürn; Raffi Bekeredjian; Taoufik Ouarrak; Horst Sievert; Georg Nickenig; Peter Boekstegers; Jochen Senges; Wolfgang Schillinger; Edith Lubos
Journal:  Eur J Heart Fail       Date:  2017-07-24       Impact factor: 15.534

6.  Validating a prediction modeling tool for left ventricular outflow tract (LVOT) obstruction after transcatheter mitral valve replacement (TMVR).

Authors:  Dee Dee Wang; Marvin H Eng; Adam B Greenbaum; Eric Myers; Michael Forbes; Patrick Karabon; Milan Pantelic; Thomas Song; Jeff Nadig; Mayra Guerrero; William W O'Neill
Journal:  Catheter Cardiovasc Interv       Date:  2017-12-11       Impact factor: 2.692

7.  Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Heart Failure.

Authors:  Michael Neuss; Thomas Schau; Akihiro Isotani; Markus Pilz; Maren Schöpp; Christian Butter
Journal:  JACC Cardiovasc Interv       Date:  2017-05-08       Impact factor: 11.195

8.  Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.

Authors:  Audrey H Wu; Keith D Aaronson; Steven F Bolling; Francis D Pagani; Kathy Welch; Todd M Koelling
Journal:  J Am Coll Cardiol       Date:  2005-02-01       Impact factor: 24.094

9.  Preoperative risk factors of medium-term mitral valve repair outcome.

Authors:  Jiangang Wang; Jie Han; Yan Li; Chunlei Xu; Yuqing Jiao; Bo Yang; Xu Meng; Steven F Bolling
Journal:  Interact Cardiovasc Thorac Surg       Date:  2014-09-12

10.  Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial.

Authors:  Tomasz Siminiak; Justina C Wu; Michael Haude; Uta C Hoppe; Jerzy Sadowski; Janusz Lipiecki; Jean Fajadet; Amil M Shah; Ted Feldman; David M Kaye; Steven L Goldberg; Wayne C Levy; Scott D Solomon; David G Reuter
Journal:  Eur J Heart Fail       Date:  2012-05-21       Impact factor: 15.534

View more
  1 in total

1.  Percutaneous Interventions for Secondary Mitral Regurgitation.

Authors:  Mahboob Ali; Satya S Shreenivas; David N Pratt; Donald R Lynch; Dean J Kereiakes
Journal:  Circ Cardiovasc Interv       Date:  2020-08-06       Impact factor: 6.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.